Chronic low back pain. Low back pain M54.5
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Persian-native speaker (Male and Female ) - Primary complaints of low back pain (more than three months, usually between the lower ribs and the creased part of the buttocks without nonspecific pathoanatomical cause) diagnosed by an experienced physiotherapist and completion of the consent form.
Exclusion criteria
Exclusion criteria: -previous spinal surgery and neurological signs specific spinal pathology (tumor, infection, fracture, inflammatory disease)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Intensity. Timepoint: Data will be assessed at the three measurement time points from the participants:•Before intervention;•After 8 weeks of intervention•At 6-month follow-up. Method of measurement: In this study, pain will be measured using Visual Analogue Scale (VAS) scale. The VAS, a widely used psychometric response scale tool, measures participants’ pain severity. Participants will be asked to indicate the severity of their pain along the VAS, which is a horizontal line with 10 points along it. The beginning shows no pain (marked with a zero and an image of a smiling face), and its endpoint (marked with a 10 and a face in pain and discomfort) represents very severe pain. Its reliability and validity have been excellent, and its internal consistency has been well demonstrated. | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-efficacy. Timepoint: Data will be assessed at the three measurement time points from the participants:• Before intervention;• After 8 weeks of intervention• At 6-month follow-up. Method of measurement: The Persian version of the Pain Self-Efficacy Questionnaire (PSEQ) will be used to assess self-efficacy. The questionnaire has been found to be a valid and reliable (ICC= 0.92) measure of pain self-efficacy beliefs). The PSEQ is a 10-item questionnaire ranging from 0 to 60 to assess patients’ confidence about their ability to perform a range of activities despite pain. For example: “I can do most of the household chores (e.g., tidying up, washing dishes), despite the pain” and “I can gradually increase my activity level, despite the pain. Lower scores for the PSEQ indicate lower levels of confidence. The least clinically significant difference (MCD) in people with CLBP is 5.5.;Fear of movement. Timepoint: Data will be assessed at the three measurement time points from the participants:• Before intervention;• After 8 weeks of intervention• At 6-month follow-up. Method of measurement: The Tampa Scale of Kinesiophobia (TSK) measures “fear of movement” or “kinesiophobia” in the patient. The total score on this scale is between, 17 to 68. For example, a score of 68 showed severe fear of movement, 37 indicates there is fear of movement and where 17 means no fear. It is translated and validated into Persian and has been reported (ICC test-retest = 0.86) (Cronbach’s Alpha was 0.796 in 17 items). The least clinically significant difference (MCD) in people with CLBP is 0.18).;Disability. Timepoint: Data will be assessed at the three measurement time points from the participants:• Before intervention;• After 8 weeks of intervention• At 6-month follow-up. Method of measurement: In the present study, The Persian version of the Oswestry questionnaire will be used to assess the degree of disability in participants with Chronic low back pain (CLBP) . This questionnaire includes | — |
Countries
Iran (Islamic Republic of)
Contacts
Kharazmi University